Your browser doesn't support javascript.
loading
Combinatorial sympathetic and cytotoxic T-lymphocyte-associated protein 4 (CTLA-4) blockades inhibit the murine melanoma growth by targeting infiltrating T cells.
Wang, Bin; Xu, Zhifang; Sunthamala, Nuchsupha; Yaguchi, Tomonori; Huang, Jin; Kawakami, Yutaka; Gong, Yinan; Tang, Huiling; Li, Shanshan; Guo, Yi; Guo, Yongming; Jinushi, Masahisa.
Afiliação
  • Wang B; Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Xu Z; Tianjin Medical University Cancer Institute and Hospital, National Clinical Research Center for Cancer, Key Laboratory of Cancer Prevention and Therapy, Tianjin's Clinical Research Center for Cancer, Tianjin, China.
  • Sunthamala N; Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Yaguchi T; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Huang J; School of Acupuncture & Moxibustion and Tuina, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Kawakami Y; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Gong Y; Department of Biology, Faculty of Science, Mahasarakham University, Mahasarakham, Thailand.
  • Tang H; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Li S; Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Guo Y; Division of Cellular Signaling, Institute for Advanced Medical Research, Keio University School of Medicine, Tokyo, Japan.
  • Guo Y; Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
  • Jinushi M; Research Center of Experimental Acupuncture Science, Tianjin University of Traditional Chinese Medicine, Tianjin, China.
Transl Cancer Res ; 10(2): 899-913, 2021 Feb.
Article em En | MEDLINE | ID: mdl-35116419

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China

Texto completo: 1 Coleções: 01-internacional Temas: Geral Base de dados: MEDLINE Tipo de estudo: Risk_factors_studies Idioma: En Revista: Transl Cancer Res Ano de publicação: 2021 Tipo de documento: Article País de afiliação: China